Skip to main content
Equibles
ICUCW logo

ICUCW · SeaStar Medical Holding Corp · Webcasts, Transcripts & Audio

Track ICUCW — free

Use ICUCW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ICUCW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.02 0.00 (-0.64%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company believes that these conditions raise substantial doubt about its ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Market Cap
$10.62M
Shares
4.41M
Volume · Oct 26 20.62K Avg daily vol (3M) 17.47K

SeaStar Medical Holding Corp Webcasts

Earnings calls, investor updates, investor days and conferences for SeaStar Medical Holding Corp (ICUCW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-12
SeaStar Medical Holding Corp (ICUCW) Q2 2026 Earnings Call Transcript
Confident tone QUELIMMUNE pediatric commercial adoption NEUTRALIZE-AKI pivotal trial enrollment Adult AKI market opportunity and FDA pathway
Revenue
$615,000
▲ 82% YoY
Gross margin
91.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
SeaStar Medical Holding Corp (ICUCW) Q1 2026 Earnings Call Transcript
Confident tone Quellimmune pediatric commercial momentum Neutralize AKI pivotal trial enrollment SCD platform broader indications
Revenue
$495,000
▲ 68.9% YoY
Gross margin
90.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
SeaStar Medical Holding Corp (ICUCW) Q4 2025 Earnings Call Transcript
Confident tone Pediatric AKI Commercial Expansion (Qualimmune) Neutralize AKI Pivotal Trial Enrollment (Adult AKI) SAVE Registry Publication and Clinical Evidence
Revenue
$420,000*
▲ 526.9% YoY
Gross margin
97.1%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-02-05
SeaStar Medical Holding Corp (ICUCW) February 5, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-13
SeaStar Medical Holding Corp (ICUCW) Q3 2025 Earnings Call Transcript
Confident tone Neutralize AKI pivotal trial enrollment Quellimmune commercial launch and pediatric site activation Neutralize CRS cardiorenal syndrome trial
Revenue
$183,000
▲ 169.1% YoY
Gross margin
92.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
SeaStar Medical Holding Corp (ICUCW) Q2 2025 Earnings Call
Revenue
$338,000
Diluted EPS
$-1.80
Gross margin
92.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
SeaStar Medical Holding Corp (ICUCW) Q1 2025 Earnings Call Transcript
Confident tone QUELIMMUNE pediatric commercial launch NEUTRALIZE-AKI adult pivotal trial Cardiac surgery breakthrough device designations
Revenue
$293,000
Diluted EPS
$-4.40
Gross margin
100.0%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
SeaStar Medical Holding Corp (ICUCW) Q4 2024 Earnings Call Transcript
Confident tone Quellimmune commercial launch NeutraLized AKI pivotal study Pipeline expansion opportunities
Revenue
$67,000*
Gross margin
100.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-12-04
SeaStar Medical Holding Corp (ICUCW) Q3 2024 Earnings Call
Revenue
$68,000
Diluted EPS
$-11.00
Gross margin
100.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-15
SeaStar Medical Holding Corp (ICUCW) Q2 2023 Earnings Call
Diluted EPS
$-41.00
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 webcasts
Key facts CIK 1831868 CUSIP 81256L302 Visit website Investor relations